心脉医疗
(688016)
| 流通市值：119.92亿 | | | 总市值：119.92亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 370,236,154.73 | 1,350,632,689.26 | 1,014,780,041.62 | 714,429,779.98 |
| 营业收入 | 370,236,154.73 | 1,350,632,689.26 | 1,014,780,041.62 | 714,429,779.98 |
| 二、营业总成本 | 190,629,159.71 | 756,503,750.61 | 563,934,629.28 | 389,156,547.64 |
| 营业成本 | 99,485,697.75 | 390,570,219.08 | 300,378,868.65 | 220,133,977.1 |
| 税金及附加 | 3,214,556.93 | 12,035,723.39 | 9,126,229.19 | 7,539,135.13 |
| 销售费用 | 46,523,579.3 | 208,295,994.19 | 151,418,849.43 | 95,878,769.37 |
| 管理费用 | 17,669,812.27 | 81,956,482.53 | 59,946,902.97 | 37,380,684.6 |
| 研发费用 | 22,172,800.94 | 67,786,192.38 | 50,922,215.9 | 36,976,562.01 |
| 财务费用 | 1,562,712.52 | -4,140,860.96 | -7,858,436.86 | -8,752,580.57 |
| 其中:利息费用 | 142,820.25 | 2,160,567.46 | 1,812,553.23 | 1,113,875 |
| 其中:利息收入 | 2,311,083.28 | 10,926,722.38 | 9,015,824.04 | 6,229,719.77 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 367,945.21 | - | - |
| 加:投资收益 | 2,503,627.63 | 15,976,849.83 | 11,603,285.95 | 7,659,856.97 |
| 资产处置收益 | -7,280.8 | - | - | - |
| 资产减值损失(新) | -1,769,033.71 | -9,271,248.76 | -7,574,592.91 | -3,850,457.37 |
| 信用减值损失(新) | -3,839,104.58 | -8,309,129.48 | -14,004,888.85 | -6,881,898.82 |
| 其他收益 | 3,441,210.47 | 61,110,920.57 | 56,593,737.7 | 44,905,553.42 |
| 四、营业利润 | 179,936,414.03 | 654,004,276.02 | 497,462,954.23 | 367,106,286.54 |
| 加:营业外收入 | 5,300.02 | 499,617.14 | 312,818.03 | 872.03 |
| 减:营业外支出 | 173,783.13 | 1,016,709.61 | 232,740.32 | 171,467.45 |
| 五、利润总额 | 179,767,930.92 | 653,487,183.55 | 497,543,031.94 | 366,935,691.12 |
| 减:所得税费用 | 27,161,866.48 | 98,827,223.89 | 74,477,858.8 | 56,310,798.71 |
| 六、净利润 | 152,606,064.44 | 554,659,959.66 | 423,065,173.14 | 310,624,892.41 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 152,606,064.44 | 554,659,959.66 | 423,065,173.14 | 310,624,892.41 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 154,841,911.99 | 563,325,654.82 | 429,055,896.79 | 314,647,223.94 |
| 少数股东损益 | -2,235,847.55 | -8,665,695.16 | -5,990,723.65 | -4,022,331.53 |
| 扣除非经常损益后的净利润 | 150,681,860.44 | 502,279,483.69 | 372,382,494.57 | 270,825,612.26 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.28 | 4.65 | 3.54 | 2.55 |
| (二)稀释每股收益 | 1.28 | 4.65 | 3.54 | 2.55 |
| 八、其他综合收益 | -15,396,170.5 | 26,839,274.01 | 38,052,254.42 | 38,073,084.01 |
| 归属于母公司股东的其他综合收益 | -15,396,170.5 | 26,839,274.01 | 38,052,254.42 | 38,073,084.01 |
| 九、综合收益总额 | 137,209,893.94 | 581,499,233.67 | 461,117,427.56 | 348,697,976.42 |
| 归属于母公司股东的综合收益总额 | 139,445,741.49 | 590,164,928.83 | 467,108,151.21 | 352,720,307.95 |
| 归属于少数股东的综合收益总额 | -2,235,847.55 | -8,665,695.16 | -5,990,723.65 | -4,022,331.53 |
| 公告日期 | 2026-04-30 | 2026-03-31 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |